Ebere Okpara

Ebere Okpara

Auto-generated profile, based on publicly available information

Ebere Okpara

Retzky College of Pharmacy University of Illinois Chicago Chicago Illinois USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2024 in Cancer Medicine
Verified
Journal Article
Open access
CGCharles E. Gaber
Charles E. Gaber
JSJyotirmoy Sarker
Jyotirmoy Sarker
AAAbdullah Abdelaziz
Abdullah Abdelaziz
EOEbere Okpara
Ebere Okpara
TLTodd A. Lee
Todd A. Lee
RNRyan Nipp
Ryan Nipp
Background: Neoadjuvant chemoradiation and chemotherapy are recommended for the treatment of nonmetastatic esophageal cancer. The benefit of neoadjuvant treatment is mostly limited to patients who exhibit pathologic complete response (pCR). Existing estimates of pCR rates among patients receiving neoadjuvant therapy have not been synthesized and lack precision.Methods: We conducted an independently funded systematic review and meta‐analysis (PROSPERO CRD42023397402) of pCR rates among patients diagnosed with esophageal cancer treated with neoadjuvant chemo(radiation). Studies were identified from Medline, EMBASE, and CENTRAL database searches. Eligible studies included trials published from 1992 to 2022 that focused on nonmetastatic esophageal cancer, including the gastroesophageal junction. Histology‐specific pooled pCR prevalence was determined using the Freeman–Tukey transformation and a random effects model.Results: After eligibility assessment, 84 studies with 6451 patients were included. The pooled prevalence of pCR after neoadjuvant chemotherapy in squamous cell carcinomas was 9% (95% CI: 6%–14%), ranging from 0% to 32%. The pooled prevalence of pCR after neoadjuvant chemoradiation in squamous cell carcinomas was 32% (95% CI: 26%–39%), ranging from 8% to 66%. For adenocarcinoma, the pooled prevalence of pCR was 6% (95% CI: 1%–12%) after neoadjuvant chemotherapy, and 22% (18%–26%) after neoadjuvant chemoradiation.Conclusions: Under one‐third of patients with esophageal cancer who receive neoadjuvant chemo(radiation) experience pCR. Patients diagnosed with squamous cell carcinomas had higher rates of pCR than those with adenocarcinomas. As pCR represents an increasingly utilized endpoint in neoadjuvant trials, these estimates of pooled pCR rates may serve as an important benchmark for future trial design.


30 September 2017 in Nigerian Journal of Animal Production
Verified
Journal Article
Open access
PDF file
SAS. A.V. Abakpa
S. A.V. Abakpa
TFT. J. Fambegbe
T. J. Fambegbe
MTM. I. Takeet
M. I. Takeet
ODO. O. Daramola
O. O. Daramola
GAG. O. Akintunde
G. O. Akintunde
EOE. O. Okpara
E. O. Okpara
African animal trypanosomosis (AAT) is one of the major constraints to the development of effective livestock production systems. Dogs are human companion and are believed to be sentinels for infection with the human species. This study was to detect subclinical and clinical infection of trypanosomes among hunting dogs in Abeokuta and its environs using molecular technique. A total of 87 dogs comprising of 49 males and 38 females were ramdomly screened for trypanosomes by polymerase chain reaction technique. Among 87 dogs screened, 17.2% were positive for Trypanosoma congolense and Trypanosoma brucei. Prevalence of trypanosomosis in males was 14.3% while the females accounted for 21.1%.Hematological examination revealed a significant increase (p < 0.05) in mean white blood cells (20.9 ± 2.11) and monocyte counts (5.9 ± 0.62) of the infected dogs compared to uninfected dogs. Packed Cell Volume (36.0 ± 3.73) and haemoglobin concentration (13.9 ± 2.10) decreased insignificantly, while, red blood cells (7.1 ± 0.87), lymphocyte (60.9 ± 9.63), neutrophil (33.3 ± 9.16) and eosinophil (1.4 ± 0.42) counts increased insignificantly (p > 0.05) in infected dogs compared to uninfected dogs. In conclusion, trypanosomosis is prevalent in hunting dogs, in Abeokuta.

7 February 2024 in JMIR Research Protocols
Verified
Journal Article
Open access
EDEllen Davis
Ellen Davis
ETElizabeth Townsend
Elizabeth Townsend
ACAero Cavalier
Aero Cavalier
YCYi-Fan Chen
Yi-Fan Chen
DEDameka Edwards-Hart
Dameka Edwards-Hart
SNSharmilee Maria Nyenhuis
Sharmilee Maria Nyenhuis
Background: Black women experience a higher prevalence of poor asthma outcomes and physical inactivity than their White counterparts. Black women comprise a particularly vulnerable group of patients with asthma, with some of the highest rates of asthma in adults, high health care use (emergency department visits and hospitalizations), and the highest crude asthma mortality rate of all race or ethnicity groups. Despite recommendations to engage in regular physical activity, fewer than 15% of Black women meet the 2008 National Physical Activity Guidelines, the lowest of all racial subgroups of adults. Given the connection between physical inactivity and poor asthma outcomes, addressing physical activity among Black women with asthma is imperative. Objective: This 2-arm randomized controlled trial aims to (1) determine the efficacy of a lifestyle walking intervention on asthma control compared to an education (control) group over 24 weeks, (2) examine the maintenance effects of the lifestyle walking intervention on asthma control at 48 weeks, (3) explore the behavioral mediators (eg, self-efficacy, social support, self-regulation, and daily physical activity levels) and contextual moderators (eg, baseline asthma severity, neighborhood environment, comorbid conditions, and social determinants of health) that contribute to treatment responsiveness, and (4) assess the reach and implementation potential of the intervention. Methods: The proposed study (ACTION [A Lifestyle Physical Activity Intervention for Minority Women with Asthma]) delivers a 24-week lifestyle walking intervention designed for and by urban Black women with asthma. Participants (n=224) will be recruited through 2 urban health care systems that care for a diverse Black population. Patients will be randomized to one of two groups: (1) ACTION intervention (group sessions, physical activity self-monitoring—Fitbit, and text-based support for step goal setting) or (2) education control (an individual asthma education session and SMS text messages related to asthma education). Outcome assessments will take place at baseline, 12, 24, and 48 weeks. The primary outcome is a change in asthma control from baseline to week 24 as assessed by the asthma control questionnaire-6 (ACQ-6). Secondary outcomes include asthma-related quality of life, health care use, and asthma exacerbations and behavioral outcomes such as self-efficacy, self-regulation, social support, and physical activity. Results: This study was funded by the National Institute of Minority Health Disparities in August 2022. We pilot-tested our recruitment and intervention procedures and began recruitment in April 2023, with the enrollment of our first participant in May 2023. The anticipated completion of the study is April 2027. Conclusions: This study will deliver a new approach to physical activity interventions in Black women with asthma and help to provide guidance for addressing physical activity within this subgroup. This study will also provide a potential framework for future studies in minoritized populations with other disease conditions associated with low levels of physical activity. Trial Registration: ClinicalTrials.gov NCT05726487; https://clinicaltrials.gov/study/NCT05726487

21 December 2023 in JMIR Preprints
Verified
Preprint
Open access
EDEllen Davis
Ellen Davis
ETElizabeth Townsend
Elizabeth Townsend
ACAero Cavalier
Aero Cavalier
YCYi-Fan Chen
Yi-Fan Chen
DEDameka Edwards-Hart
Dameka Edwards-Hart
SNSharmilee Maria Nyenhuis
Sharmilee Maria Nyenhuis
BACKGROUND Black women experience a higher prevalence of poor asthma outcomes and physical inactivity than their White counterparts. Black women comprise a particularly vulnerable group of patients with asthma, with some of the highest rates of asthma in adults, high health care use (emergency department visits and hospitalizations), and the highest crude asthma mortality rate of all race or ethnicity groups. Despite recommendations to engage in regular physical activity, fewer than 15% of Black women meet the 2008 National Physical Activity Guidelines, the lowest of all racial subgroups of adults. Given the connection between physical inactivity and poor asthma outcomes, addressing physical activity among Black women with asthma is imperative. OBJECTIVE This 2-arm randomized controlled trial aims to (1) determine the efficacy of a lifestyle walking intervention on asthma control compared to an education (control) group over 24 weeks, (2) examine the maintenance effects of the lifestyle walking intervention on asthma control at 48 weeks, (3) explore the behavioral mediators (eg, self-efficacy, social support, self-regulation, and daily physical activity levels) and contextual moderators (eg, baseline asthma severity, neighborhood environment, comorbid conditions, and social determinants of health) that contribute to treatment responsiveness, and (4) assess the reach and implementation potential of the intervention. METHODS The proposed study (ACTION [A Lifestyle Physical Activity Intervention for Minority Women with Asthma]) delivers a 24-week lifestyle walking intervention designed for and by urban Black women with asthma. Participants (n=224) will be recruited through 2 urban health care systems that care for a diverse Black population. Patients will be randomized to one of two groups: (1) ACTION intervention (group sessions, physical activity self-monitoring—Fitbit, and text-based support for step goal setting) or (2) education control (an individual asthma education session and SMS text messages related to asthma education). Outcome assessments will take place at baseline, 12, 24, and 48 weeks. The primary outcome is a change in asthma control from baseline to week 24 as assessed by the asthma control questionnaire-6 (ACQ-6). Secondary outcomes include asthma-related quality of life, health care use, and asthma exacerbations and behavioral outcomes such as self-efficacy, self-regulation, social support, and physical activity. RESULTS This study was funded by the National Institute of Minority Health Disparities in August 2022. We pilot-tested our recruitment and intervention procedures and began recruitment in April 2023, with the enrollment of our first participant in May 2023. The anticipated completion of the study is April 2027. CONCLUSIONS This study will deliver a new approach to physical activity interventions in Black women with asthma and help to provide guidance for addressing physical activity within this subgroup. This study will also provide a potential framework for future studies in minoritized populations with other disease conditions associated with low levels of physical activity. CLINICALTRIAL ClinicalTrials.gov NCT05726487; https://clinicaltrials.gov/study/NCT05726487 INTERNATIONAL REGISTERED REPORT DERR1-10.2196/55700